Share Name Share Symbol Market Type Share ISIN Share Description
Spectra (Unres) LSE:SPSY London Ordinary Share US84756T1060 COM SHS USD0.01 (UNRES)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +4.50p +5.11% 92.50p 90.00p 95.00p 92.50p 88.00p 88.00p 188,334 14:55:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 9.0 0.9 2.4 42.7 42.03

Spectra (Unres) (SPSY) Latest News

More Spectra (Unres) News
Spectra (Unres) Takeover Rumours

Spectra (Unres) (SPSY) Share Charts

1 Year Spectra (Unres) Chart

1 Year Spectra (Unres) Chart

1 Month Spectra (Unres) Chart

1 Month Spectra (Unres) Chart

Intraday Spectra (Unres) Chart

Intraday Spectra (Unres) Chart

Spectra (Unres) (SPSY) Discussions and Chat

Spectra (Unres) Forums and Chat

Date Time Title Posts
21/1/201818:05*** Spectra ***1,824

Add a New Thread

Spectra (Unres) (SPSY) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Spectra (Unres) trades in real-time

Spectra (Unres) (SPSY) Top Chat Posts

Spectra (Unres) Daily Update: Spectra (Unres) is listed in the Support Services sector of the London Stock Exchange with ticker SPSY. The last closing price for Spectra (Unres) was 88p.
Spectra (Unres) has a 4 week average price of 80.50p and a 12 week average price of 75p.
The 1 year high share price is 112p while the 1 year low share price is currently 35p.
There are currently 45,434,754 shares in issue and the average daily traded volume is 257,142 shares. The market capitalisation of Spectra (Unres) is £42,027,147.45.
microscope: All good points guys, thanks. We are all on the same page. The value argument is undeniable, and I agree the yield in a sense underpins the share price too. You're right that the shares are strongly undervalued. My thought is just that another broker could unlock the value here by attracting new investors, which Ireland haven't done recently in my opinion. Exactly what Tilly predicted, the rise would be followed by Ireland forcing the price down again, and I want to wait and see how it settles before committing. If I miss the boat so be it, but not overly worried because I think that once it does break out, it could go a very long way higher over a year or two. One or two rises won't be the end of it - just the beginning.
fft: microscope, are you saying that you are holding off because of the overhang ? I would look at the yield as something that helps underpin the share price. With the increase in various activities it is surely a growth stock - but unlike most growth stocks that have high p/e's, no dividend and a useless balance sheet, this one has a rock solid balance sheet and a yield that beats leaving the money in the bank. In my mind, that makes this an ideal time to buy as when the overhang is cleared the share price should rise a few pennies. Unless I am missing something which I should know. It is very easy to get blinkered and only look for confirmation bias which is why counter arguments are always good to read.
harrogate: I am not expecting a further beat for 2017 now based on the wording of the last one which was all around having visibility on royalties from DLR ( we assume ) earlier than normal - I think this was a signal that this was it. The key now is this from the early Sept update "In addition, based on the recent approval in China of our materials for smartphone authentication, we expect to undertake important large scale production testing and validation of the technology for use in the tobacco industry this year." We could do with knowing if that did happen and if not why not - that for me is the crucial piece of information we need to know. If this opportunity has gone for whatever reason it will need a very decent announcement on the dividend outlook to avoid some share price disappointment in the short term.
simso: Here's an idea which could kill a few birds with one stone. As I have posted before, I do believe SPSY will deliver EBITDA $5m to Dec 17, and close the year with a cash balance of $11m - $12m. In March 17 SPSY said that a target $5m Cash Balance was sufficient for its needs. However, with such a big seller in the background, it is possible that even when the "significantly ahead" statement I expect in early Jan will not give the share price the boost we deserve. One solution could be for SPSY to use some cash in the same way that another of my large holdings did recently. Volvere used £3.5m of its cash resources in an offer to all shareholders to buy back shares at current market price. The majority of us delined to sell, and saw our % holdings slightly increase, while one large weak holder had the chance to substantially reduce. THis could be a great route for SPSY to take. It could clear that big seller and am sure the shares would bounce significantly when he is out. It would deploy some of the large cash pile in a tax efficient way for all of us. The alterntaive dividend route does attract that annoying Witholding Tax. Thoughts?
bones: Tilly, I guess everyone is awaiting the year end update in early January. Given the optimism in the last announcement about substantially exceeding expectations, I am expecting the share price to tick upward before then in anticipation of a solid update. After all, the price is currently below what it was before that last update. Its almost as though the market doesn't believe it.
microscope: Ha Tilly I can see you have been doing some 'homework'! :) I am no better than the next person to be fair, but compliment appreciated, still prone to some poor choices, but do have the one 'advantage' of having been round the block and can remember the 1987 crash as well as of course the bubble market of the early 'no(a?)ughties'.... This stock was mentioned to me at a party.... Yes I know what you're probably thinking... :) but by a seasoned market player who has a stake himself for the long term. That was before the recent RNS about this year's profits exceeding, and a very positive if perhaps not quite as exciting outlook for next year. i like the market, the technology and feel of a fairly unexploited marketplace, but do wonder what barriers to entry are. For what it's worth I think AIM is in another mini-bubble that not everyone (some have) has rumbled yet. More opportunities but with it more danger. LTG has doubled this year, as you can see from the chart this one has trebled in 2017, WEY education announced a profit of 17k the other day and went from 16p to 30p (30+ million market cap).... I could go on (and on...). Loads more examples this year. Wey has a lovely niche market that can be exploited, but it will take far longer than current investors think. When you cut through it, LTG's first half was actually a small loss, and yes they are going to make very decent profits at the end of the year and next year (contracts with blue chips such as the civil service etc, and a superb management who have made the right acquisitions at the right time), but a market cap of a quarter of a billion and rising? I'm riding the momentum there and I like to run my winners, but there's a point where however good Andrew Brode and Satchell are, that market cap will become unsustainable. Ashley House has a chunk of debt and therefore the risk has to be acknowledged, however government turnaround on residential schemes announced last week means they can 'unlock' a whole swathe of projects which have been frozen for some years now. It's easy and quick to do - and can transform the business, though it will only feed their bottom line in 2018-2019, however when it does, the share price will probably be multiples of today. I think their rise, unlike LTG and WEY, has got real substance to it and is a runner. You might make a fast buck trading it, but I think the longer term reward is worth going for and fwiw it would be my current pick. They are a dull enough company who have been around a long time and doubtless the new found volatility will continue awhile, but once things settle down again the share price should head north nicely. But as I said at the beginning, I've been horribly wrong before, Tilly. What are your current favs?
pj 1: Buy the Company not the share price??? Its so illiquid it's impossible to call short term price movements imo, PEL being a perfect example
mctmct: SPSC price briefly overtook the SPSY price!
tilly99: Hi guys Not going into much detail as on a train at momentI felt the meeting went well and for me the share price is a true reflection of where we areIf you think Trubrand or Aeris has decent prospects then buy the shares as the upside is still substantial Trubrand could be worth upto 200p on the share pricePersonally I have no major hopes for aeris but trubrand has a good (maybe 75 pct) chance of success(not necessarily as much as 200p)So buy spsy on a dull day There were other posters at the meeting so they will expand in sure plus give their own opinions
patviera: RmIs 600/- bucks salary for Lawandy outrageous in this tiny little company??Surely better to have compensation linked to spsy share price??450 gbp must be the highest salary for a CEO on AimWhy???!!!
Spectra (Unres) share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20180121 18:33:17